The research is the first to document that an obesity medication can not only pare pounds, but also safely prevent a heart attack, stroke or a heart-related death in people who already have heart disease—but not diabetes.
The current water study is examining the art of the possible—if appropriate need should exist in the future to move water from the Lafayette region to central Indiana. Indiana is blessed with more than adequate water resources; they’re just not always precisely where we need them.
The Indianapolis-based drug company is ramping up manufacturing capacity to avoid possible shortages and to meet potentially huge demand in a nation where more than 40% of adults are classified as obese.
Eli Lilly and Co.’s hot-selling diabetes drug, Mounjaro, will now be sold for a second use, chronic weight management, using a separate brand name, Zepbound.
Excluding nonrecurring items, the Indianapolis-based drugmaker posted adjusted earnings of 10 cents a share, beating Zacks consensus estimate of a loss of 11 cents a share.
The group, “Stop the Water Steal,” plans to lead a letter-writing campaign to local and state officials, urging them to stop the pipeline, slow its progress or minimize its impact on community water resources.
IU’s newest plans are intended to bolster enrollment and establish Indiana University Indianapolis as one of the country’s premier urban research universities.
It is time for a change, pure and simple. We are starved for leadership in this city. And leadership starts at the top. I believe Jefferson Shreve can bring that leadership.
Eli Lilly and Co. will study its blockbuster diabetes drug Mounjaro in combination with an experimental muscle-loss treatment as it searches for ways to help patients maintain muscle while losing weight.
The Indiana Economic Development Corp. signed a $3.5 million contract with Southfield, Michigan-based advertising firm Doner Co. to develop the branding initiative.
The federal designation marks Indiana as a hub for biologics manufacturing. Biologics are medicines derived from biological sources and include vaccines, monoclonal antibodies, and immune modulators.
The technology hub designation makes Indiana eligible to compete against 30 other designated hubs in hopes of landing up to $70 million in federal funding to implement its program.
Indianapolis Mayor Joe Hogsett’s fundraising wasn’t able to keep pace with Republican challenger Jefferson Shreve’s ability to bankroll his own campaign.
The move comes five months after the utility company agreed to supply up to 10 million gallons of water to the advanced manufacturing district by 2027.
As one of Elanco Animal Health’s top legal executives, Shiv O’Neill is a trusted adviser who anticipates issues and develops strategies to mitigate risk and achieve commercial goals.
